Filing Details

Accession Number:
0001140361-11-019814
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-31 17:35:18
Reporting Period:
2011-03-30
Filing Date:
2011-03-31
Accepted Time:
2011-03-31 17:35:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
730272 Repligen Corp RGEN Biological Products, (No Disgnostic Substances) (2836) 042729386
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1241031 R James Rusche C/O Repligen Corporation
41 Seyon Street, Building 1, Suite 100
Waltham MA 02453
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-03-30 5,000 $2.66 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-03-30 20,000 $1.04 20,000 $2.66
Common Stock Stock Option (Right to Buy) Disposition 2011-03-30 5,000 $0.00 5,000 $2.66
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2006-04-03 2011-04-03 No 4 D Direct
0 2006-04-03 2011-04-03 No 4 M Direct
Footnotes
  1. The option was cancelled by mutual agreement of the Rporting Person and the Issuer in advance of its scheduled expiration date. The Reporting Person received the difference between $3.70, the closing price of the ISsuer's Common Stock on the transaction date, and $2.66, the exercise price of the stock option, less any applicable withholding taxes.